INOZYME PHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.65 USD | +0.22% |
|
0.00% | +9.15% |
| May. 07 | Inozyme Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 08 | Transcript : Inozyme Pharma, Inc. - Special Call |
Chart calendar Inozyme Pharma, Inc.
64180d8b1465974e97c50bbeb3540.vGaSTWqMJCdT8YBqv_JAAp0Pg5zcd0ufpPOOlnoAkTU.5VP3FAbkFhUmkPkt6K0raMxZtsPxOTPW_avIwjli_mqJAKcYIr9TSBiixQ~42465fa16b7e30003a69b7689ddeb73f
Upcoming events on Inozyme Pharma, Inc.
Past events on Inozyme Pharma, Inc.
| 2024-05-07 08:30 am | Q1 2024 Earnings Release |
| 2024-04-09 10:15 am | Needham Healthcare Conference |
| 2024-04-08 08:00 am | INZ-701 Phase 1/2 Trial Results Call |
| 2024-03-12 08:30 am | Q4 2023 Earnings Release |
| 2024-03-04 09:10 am | TD Cowen Health Care Conference |
| 2023-11-30 12:00 pm | Piper Sandler Healthcare Conference |
| 2023-11-16 03:00 am | Jefferies London Healthcare Conference |
| 2023-11-07 08:30 am | Q3 2023 Earnings Release |
| 2023-11-02 05:42 pm | American Society of Nephrology Kidney Conference |
| 2023-10-15 04:30 pm | American Society for Bone and Mineral Research Meeting |
| 2023-10-14 04:30 pm | American Society for Bone and Mineral Research Meeting |
| 2023-10-14 04:30 pm | American Society for Bone and Mineral Research Meeting - ENPP1 |
| 2023-10-13 09:00 pm | American Society for Bone and Mineral Research Meeting - ABCC6 |
| 2023-10-13 09:00 pm | American Society for Bone and Mineral Research Meeting |
| 2023-09-26 08:00 am | INZ-701 Phase 1/2 and ABCC6 Deficiency Trail Results Call |
| 2023-09-11 12:00 pm | H.C. Wainwright Global Investment Conference |
| 2023-08-08 08:30 am | Q2 2023 Earnings Release |
| 2023-07-26 08:00 am | Business Update Call |
| 2023-06-13 10:00 am | Annual General Meeting |
| 2023-06-09 09:30 am | Jefferies Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -56,8 -59,7 4.83% | -56,0 -58,8 4.75% | -67,9 -66,2 -2.6% | -74,8 -71,8 -4.15% | -93,8 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -57,0 -58,2 2.02% | -56,6 -55,5 -1.99% | -68,7 -68,6 -0.17% | -75,6 -72,8 -3.87% | -104 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -56,4 -57,5 1.94% | -56,6 -55,4 -2.2% | -67,1 -67,9 1.2% | -71,2 -69,3 -2.71% | -101 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -56,4 -57,5 1.94% | -56,6 -55,4 -2.2% | -67,1 -67,9 1.2% | -71,2 -69,3 -2.69% | -101 |
|
EPS USD | Released Forecast Spread | -2,23 | -5,11 -4,65 -9.83% | -2,40 -2,30 -4.58% | -1,78 -1,81 1.66% | -1,37 -1,34 -1.91% | -1,59 |
| Announcement Date | 02/07/20 | 25/03/21 | 15/03/22 | 22/03/23 | 12/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -16,8 -19,6 14.2% | -15,4 -18,9 18.77% | -16,9 -17,5 3.24% | -19,5 -19,4 -0.52% | -18,4 -20,0 7.95% | -16,4 -19,5 16.11% | -18,1 -19,3 6.24% | -22,8 -20,0 -14.03% | -24,3 -22,9 -6.36% | -25,1 | -26,6 | -28,1 | -31,0 | -32,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,9 -19,6 14.05% | -15,3 -19,2 20.56% | -16,4 -17,7 7.35% | -18,5 -19,6 5.19% | -17,4 -19,7 11.62% | -15,6 -19,4 19.7% | -16,6 -18,9 12.14% | -21,5 -19,4 -11.18% | -23,3 -22,2 -5.1% | -24,8 | -26,6 | -28,3 | -30,7 | -32,5 |
|
Net income Million USD | Released Forecast Spread | -16,9 -19,5 13.63% | -15,3 -18,9 19.41% | -16,4 -17,4 5.91% | -18,5 -19,4 4.25% | -17,4 -19,7 11.52% | -15,6 -19,3 19.13% | -16,6 -18,7 11.2% | -21,5 -19,4 -11.15% | -23,3 -22,0 -5.98% | -24,3 | -25,9 | -27,4 | -30,7 | -32,5 |
|
EPS USD | Released Forecast Spread | -0,71 -0,82 13.59% | -0,38 -0,48 20.6% | -0,38 -0,43 12.5% | -0,31 -0,45 31.37% | -0,40 -0,45 10.26% | -0,35 -0,43 19.41% | -0,29 -0,32 8.56% | -0,35 -0,32 -9.87% | -0,38 -0,36 -6.15% | -0,39 | -0,40 | -0,42 | -0,46 | -0,43 |
| Announcement Date | 10/05/22 | 15/08/22 | 10/11/22 | 22/03/23 | 09/05/23 | 08/08/23 | 07/11/23 | 12/03/24 | 07/05/24 | - | - | - | - | - |
More events
Past sector events for Inozyme Pharma, Inc.
| Today | HUMACYTE, INC.: Q1 2024 Earnings Release |
| Today | NOVAVAX, INC.: Q1 2024 Earnings Release |
| Today | TAKARA BIO INC.: Q4 2023 Earnings Release |
| Today | CHABIOTECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-05-09 04:05 pm | BIOHAVEN LTD.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | OMNIAB, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | 4D MOLECULAR THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 08:00 am | CG ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 2024-05-09 08:00 am | DISC MEDICINE, INC.: Q1 2024 Earnings Release |
| 2024-05-09 08:00 am | VERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- INZY Stock
- Calendar Inozyme Pharma, Inc.